Quick Takeaways
- Smith Jeffrey T. L. has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,396,540.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Smith Jeffrey T. L.
- Location
- Bothell, WA
- Summary
- The estimated net worth of Smith Jeffrey T. L. is at least $1,396,540 dollars as of 12 Jan 2026. Smith Jeffrey T. L. is the EVP & Chief Medical Officer of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $1.4M.
- Signature
- /s/ Daniel Dex, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Smith Jeffrey T. L. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Zymeworks Inc. ($1,396,540).
- Past-year value change for that position: -$475,561.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Smith Jeffrey T. L.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | EVP & Chief Medical Officer | $1,396,540 | -$475,561 | -25% | 12 Jan 2026 |
Insider Transactions Reported by Smith Jeffrey T. L.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.